In the head‐to‐head comparisons, plasma p‐tau217 and p‐tau217/Aβ42 performed equivalently to the CSF Aβ42/40 and p‐tau181/Aβ42 ratios in determining Aβ and tau PET positivity and diagnosing AD. Here, MAPT is linked to Alzheimer disease.